BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6652203)

  • 21. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exact permutational tests for group sequential clinical trials.
    Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
    Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early stopping rules in clinical trials based on sequential monitoring of serious adverse events.
    Kramar A; Bascoul-Mollevi C
    Med Decis Making; 2009; 29(3):343-50. PubMed ID: 19073996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial.
    Hughes S; Cuffe RL; Lieftucht A; Garrett Nichols W
    Pharm Stat; 2009; 8(1):25-37. PubMed ID: 18383194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interim analyses for randomized clinical trials: the group sequential approach.
    Pocock SJ
    Biometrics; 1982 Mar; 38(1):153-62. PubMed ID: 7082757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplementary analysis of probabilities at the termination of a group sequential phase II trial.
    Liu A; Wu C; Yu KF; Gehan E
    Stat Med; 2005 Apr; 24(7):1009-27. PubMed ID: 15565737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantile-function based null distribution in resampling based multiple testing.
    van der Laan MJ; Hubbard AE
    Stat Appl Genet Mol Biol; 2006; 5():Article14. PubMed ID: 17049025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Mar; 26(7):1431-49. PubMed ID: 17066402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of restricted sequential design in a clinical protocol.
    Thompson EI
    Cancer Treat Rep; 1980; 64(2-3):399-403. PubMed ID: 7407776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring clinical trials with a conditional probability stopping rule.
    Snapinn SM
    Stat Med; 1992 Mar; 11(5):659-72. PubMed ID: 1594808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of two or more samples of quantitative data].
    Ivanković D; Tiljak MK
    Acta Med Croatica; 2006; 60 Suppl 1():37-46. PubMed ID: 16526306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical models for protein validation using tandem mass spectral data and protein amino acid sequence databases.
    Sadygov RG; Liu H; Yates JR
    Anal Chem; 2004 Mar; 76(6):1664-71. PubMed ID: 15018565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential clinical trials in cancer research.
    George SL
    Cancer Treat Rep; 1980; 64(2-3):393-7. PubMed ID: 7407775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
    Johnson VE; Cook JD
    Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of procedures for testing the equality of survival distributions.
    Joe H; Koziol JA; Petkau AJ
    Biometrics; 1981 Jun; 37(2):327-40. PubMed ID: 7272418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A procedure for group sequential comparative poisson trials.
    Xia Q; Hoover DR
    J Biopharm Stat; 2007; 17(5):869-81. PubMed ID: 17885871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm.
    Goldman AI; Hannan PJ
    Stat Med; 2001 Jun; 20(11):1575-89. PubMed ID: 11391689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.